Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain
the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in
Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles
and JavaScript.
A collective effort from materials scientists, life scientists and clinicians is required to systematically address fundamental questions in the mechanisms of nanoparticle delivery in order to overcome the hurdles in translating nanomedicines for tumour therapy.
New evidence suggests that the mechanism of nanoparticle entry into solid tumours may be driven by an active process. This insight paves the way for approaches to enhance the efficiency of nanomedicine delivery by harnessing active transport mechanisms, and encourage researchers to rethink how tumours are treated.
Now more than ever before, it is vitally important for scientists, clinicians and policymakers to communicate the significance of vaccination to the public in order to counteract the spread of misinformation.
This is a turning point for nanofluidics. Recent progress allows envisioning both fundamental discoveries for the transport of fluids at the ultimate scales, and disruptive technologies for the water–energy nexus.
Materials discovery and developments in nanofabrication and our understanding of transport at the nanoscale are supporting the rapid development of nanofluidics and accelerating its technological translation.